USD 0.04
(1.27%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 179.96 Thousand USD | 213.56% |
2022 | 57.39 Thousand USD | 0.0% |
2021 | 57.39 Thousand USD | -73.99% |
2020 | 220.68 Thousand USD | 1658.41% |
2019 | 12.55 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 9715.00 USD | -50.19% |
2008 | 19.5 Thousand USD | -97.04% |
2007 | 658.89 Thousand USD | 967.8% |
2006 | 61.7 Thousand USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 269.03 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 160.99 Thousand USD | 0.0% |
2024 Q2 | 140.96 Thousand USD | 0.0% |
2023 FY | 179.96 Thousand USD | 213.56% |
2023 Q4 | 179.96 Thousand USD | -8.81% |
2023 Q3 | 197.35 Thousand USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2022 Q3 | 10.77 Thousand USD | -59.74% |
2022 Q1 | 42.24 Thousand USD | -26.39% |
2022 Q4 | 57.39 Thousand USD | 432.7% |
2022 FY | 57.39 Thousand USD | 0.0% |
2022 Q2 | 26.76 Thousand USD | -36.66% |
2021 Q2 | 81.63 Thousand USD | -14.71% |
2021 Q1 | 95.71 Thousand USD | -56.63% |
2021 FY | 57.39 Thousand USD | -73.99% |
2021 Q4 | 57.39 Thousand USD | -20.35% |
2021 Q3 | 72.06 Thousand USD | -11.73% |
2020 FY | 220.68 Thousand USD | 1658.41% |
2020 Q1 | - USD | -100.0% |
2020 Q4 | 220.68 Thousand USD | 0.0% |
2019 Q4 | 12.55 Thousand USD | -2.54% |
2019 FY | 12.55 Thousand USD | 0.0% |
2019 Q3 | 12.87 Thousand USD | -48.88% |
2019 Q2 | 25.19 Thousand USD | -33.41% |
2019 Q1 | 37.83 Thousand USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q1 | 6773.00 USD | -30.28% |
2010 Q4 | - USD | -100.0% |
2010 FY | - USD | -100.0% |
2010 Q3 | 1677.00 USD | 0.0% |
2010 Q2 | - USD | -100.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | -100.0% |
2009 Q1 | 14.23 Thousand USD | -27.01% |
2009 FY | 9715.00 USD | -50.19% |
2009 Q4 | 9715.00 USD | 0.0% |
2008 FY | 19.5 Thousand USD | -97.04% |
2008 Q3 | 23.67 Thousand USD | -97.87% |
2008 Q2 | 1.11 Million USD | 23.35% |
2008 Q1 | 901.5 Thousand USD | 36.82% |
2008 Q4 | 19.5 Thousand USD | -17.59% |
2007 Q2 | 43.52 Thousand USD | -12.23% |
2007 Q4 | 658.89 Thousand USD | 87.69% |
2007 FY | 658.89 Thousand USD | 967.8% |
2007 Q3 | 351.05 Thousand USD | 706.64% |
2007 Q1 | 49.58 Thousand USD | -19.64% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | 61.7 Thousand USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 FY | 61.7 Thousand USD | 0.0% |
2005 FY | - USD | -100.0% |
2005 Q3 | - USD | -100.0% |
2005 Q1 | 269.01 Thousand USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | 269.01 Thousand USD | 0.0% |
2004 FY | 269.03 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | -Infinity% |
Ansell Limited | 705.27 Million USD | 99.974% |
Ansell Limited | 706.6 Million USD | 99.975% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 99.197% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | - USD | -Infinity% |
Psykey, Inc. | 625 Thousand USD | 71.206% |
ConvaTec Group Plc | 1.22 Billion USD | 99.985% |
ConvaTec Group Plc | 1.22 Billion USD | 99.985% |
Encision Inc. | 67.33 Thousand USD | -167.261% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 382.83 Thousand USD | 52.992% |
LifePoint, Inc. | 151.73 Thousand USD | -18.604% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 96.338% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 70.738% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
SmileDirectClub, Inc. | 849.37 Million USD | 99.979% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.915% |
SheerVision, Inc. | - USD | -Infinity% |
United Health Products, Inc. | 48.48 Thousand USD | -271.142% |
Vasamed, Inc. | 18.95 Thousand USD | -849.673% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | -874.459% |
Yubo International Biotech Limited | 390.44 Thousand USD | 53.908% |